20 November 2026
Azenta, Inc.
CIK: 933974•2 Annual Reports•Latest: 2026-11-19
Disclaimer: AI-assisted summary of SEC Form 10-K filings. Not official company content and not investment, legal, accounting, or tax advice. See full disclaimer here.
10-K / November 19, 2026
Revenue:$621,703,000
Income:-$166,985,000
10-K / November 27, 2024
Revenue:$656,300,000
Income:-$164,200,000
10-K / November 19, 2026
Azenta, Inc.
Overview
Azenta provides biological and chemical sample exploration and management solutions for the life sciences industry. The company supports customers across research, clinical development and commercialization with a portfolio centered on automated storage and sample management and genomic services.
Core offerings
- Sample management and automated storage systems
- Genomic services
- Consumables, informatics and data software
- Sample repository services
- Services across the full sample lifecycle, including procurement and storage
Business model and growth approach
- Combines internally developed products with acquisitions to expand capabilities
- Focuses on accelerating time to market for life sciences solutions through product development, strategic investments and integration of acquired technologies
Global footprint and scale
- Operations in North America, Asia and Europe
- Sales in approximately 87 countries
- Approximately 2,850 full-time, part-time and contingent workers worldwide as of September 30, 2026
- Headquartered in Burlington, Massachusetts
Corporate history and structure
- Founded in 1978; originally known as Brooks Automation, Inc.
- Changed corporate name to Azenta, Inc. on December 1, 2021; trades on Nasdaq under the symbol AZTA
- Since 2022, focused on life sciences after divesting semiconductor businesses
- Divested B Medical Systems in July 2026 for $63.0 million in cash
- Semiconductor automation results and B Medical Systems are presented as discontinued operations
